FOSL1 and cancer: Based on the role of Fra-1 in cancer metastasis including mCRC, it is proposed that removing Fra-1 by inhibiting Fra-1 DUBs can be a promising strategy for mCRC treatment, since many Fra-1 target genes relevant to cancer metastasis can be downregulated simultaneously by removing or decreasing the stability of Fra-1.